Related Experiment Video
Updated: Feb 25, 2026
08:13
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
6.5K
Exosomes: A Rising Star in Falling Hearts.
Jun-Yan Xu1, Gui-Hao Chen1, Yue-Jin Yang1
1State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical CollegeBeijing, China.
Frontiers in Physiology
|July 29, 2017
Summary
Exosomes, once thought to discard cellular waste, are now known to mediate cell-cell communication. These vesicles carry molecules that impact cardiovascular diseases (CVDs), offering potential as biomarkers and therapeutics.
Area of Science:
- * Molecular Biology
- * Cellular Biology
- * Cardiovascular Research
Background:
- * Exosomes are extracellular vesicles involved in intercellular communication.
- * They transport nucleic acids, proteins, and lipids, influencing target cell behavior.
- * Exosomes play a significant role in the pathogenesis of various cardiovascular diseases (CVDs).
Purpose of the Study:
- * To summarize the effects of exosome-derived molecules on cardiac function.
- * To explore the potential of exosomes as biomarkers for CVDs.
- * To examine the therapeutic applications of exosomes in treating CVDs.
Main Methods:
- * Literature review of studies on exosome function in cardiovascular diseases.
- * Analysis of exosome-derived microRNAs and proteins.
- * Examination of exosome involvement in myocardial infarction, cardiomyopathy, and pulmonary arterial hypertension.
Main Results:
- * Exosome-derived molecules, particularly microRNAs and proteins, significantly influence cardiac function.
- * Evidence suggests exosomes are extensively involved in the progression of diverse cardiovascular diseases.
- * Specific exosomal contents can modulate cellular behavior relevant to cardiovascular health.
Conclusions:
- * Exosomes are critical mediators of cell-cell communication in the context of cardiovascular diseases.
- * Exosome-derived molecules hold promise as potential biomarkers for early detection and diagnosis of CVDs.
- * Exosomes represent a promising avenue for novel therapeutic strategies targeting cardiovascular conditions.
Related Concept Videos
01:36Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
01:29Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
01:17Pathophysiology of Heart Failure
4.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
01:27Heart Failure I: Introduction
1.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K
01:22Heart Failure VI: Adjunct Therapies
442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K